Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lenalidomide.php on line 2
Lenalidomide
LE WE PMID CA
Lenalidomide4336Lenalidomid

Autoimmunity

Azacitidine

Decitabine

Lenalidomide

Leukemia (chronic lymphatic)

Myelodysplastic syndrome

PCD (Multiple myeloma and other plasma cell dyscrasias)

Pomalidomide

2008  
1
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma.
[18728702] Ther Clin Risk Manag 4(1): 129-36 (2008)
2007  
2
Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.
[18472976] Ther Clin Risk Manag 3(4): 553-62 (2007)
2010  
3
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy.
[20694078] Core Evid 4(-): 215-45 (2010)
2006  
4
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
[17043184] Arch Dermatol 142(10): 1298-302 (2006)
2006  
5
Lenalidomide: from bench to bedside (part 1).
[17242660] Cancer Control 13 Suppl(-): 2-3 (2006)
2006  
6
Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.
[17242661] Cancer Control 13 Suppl(-): 4-11 (2006)
2006  
7
Evolving applications of lenalidomide in the management of anemia in myelodysplastic syndromes.
[17242662] Cancer Control 13 Suppl(-): 12-6 (2006)
2009  
8
2008  
9
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.
[18265982] Ann Hematol 87(5): 345-52 (2008)
2009  
10
Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.
[19734414] Haematologica 94(9): 1198-202 (2009)
2010  
11
How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.
[21239812] Hematology Am Soc Hematol Educ Program 2010(-): 314-21 (2010)
2005  
12
Recent clinical studies of the immunomodulatory drug (IMiD) lenalidomide.
[16222306] Br J Cancer 93(6): 613-9 (2005)
2009  
13
Mechanism of action of lenalidomide in hematological malignancies.
[19674465] J Hematol Oncol 2(-): 36 (2009)
2007  
14
Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
[17723971] Clin J Oncol Nurs 11(4): 569-74 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lenalidomide.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lenalidomide.php on line 92